Adherence to antiretroviral therapy among HIV-infected children receiving care at Kilimanjaro Christian Medical Centre (KCMC), Northern Tanzania: A cross- sectional analytical study

Adherence to antiretroviral therapy among HIV-infected children receiving care at Kilimanjaro Christian Medical Centre (KCMC), Northern Tanzania: A cross- sectional analytical study

 

Amos Haki Nsheha^1,&, Dorothy Elizabeth Dow², Gabriel Erick Kapanda³, BernadiusCarmilus Hamel⁴, Levina January Msuya¹

 

¹Department of Paediatrics and Child Health, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania, ²KCMC- Duke Collaboration, P.O Box 3010, Moshi, Tanzania, ³Department of Epidemiology & Biostatistics, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania, ⁴Directorate of Postgraduate Studies, Kilimanjaro Christian Medical University College, P.O Box 2240, Moshi, Tanzania

 

 

^&Corresponding author
Amos Haki Nsheha, Kilimanjaro Christian Medical University College, P. O. Box 2240, Moshi, Tanzania

 

 

 

 

More than two million children are infected with HIV globally and sub-Saharan Africa bears more than 90% of the global HIV burden [1]. In Tanzania, the HIV epidemic has spread rapidly to all districts and communities and affected all sectors of the society. The estimated HIV prevalence was 5.7% in 2009 equivalent to 1.4 million people; approximately 96,000 died of AIDS in 2008 and only 55.2% of the 425,725 children and adults who qualify forART received treatment [2].

HIV/AIDS requires long-term treatment and adherence to medication is believed to decrease with time. For patients taking daily medication, the exercise is tedious and in six months, compliance to medication was shown to decrease significantly [3].

Adherence requires dedication of both the child and caregivers to consistently follow treatment recommendations [4]. Not only do the child and caregivers need to be committed to treatment, but a variety of other factors may complicate ART adherence in children [5].

With introduction and successful use of Highly Active Antiretroviral Therapy (HAART),HIV-infected children are surviving into adolescence and facing many adherence challenges associated with long-term therapy [5].Poor adherence increases the risk of virologic failure and viral resistance, therefore, optimal adherence (> 95% of pills taken) is the key to success in HIV infected children who are onlong term treatment [4].

Many developing countries have a high rate of treatment failure among HIV-infected children who are on ART, including those in Tanzania [5]. At KCMC, approximately 20% of 400 children are on second line regimen following failure of the first line regimen.

Children on treatment are surviving longer and reach adolescence, a stage of life which has high risk for engaging in sexual behaviour possibly resulting in transmission of a resistant HIV strain.

The aim of this study was to determine the rate of adherence and factors associated with adherence to antiretroviral therapy among HIV-infected children.

 

 

This study was conducted at the Child Centred Family Care Clinic (CCFCC) of KCMC, a tertiary hospital, from September 2011 to April 2012. It wasa cross-sectional study thatmeasured adherence levels to ARV drugs and examined demographic and other characteristics of the respondents. The study population included HIV- infected children aged 2 to 17 years on ARVs.

One hundred and eighty three children as well as their caregivers agreed to participate and signed informed consent. Participants were interviewed using a structured questionnaire to obtain demographic characteristics of respondents and subjected to all adherence measurement tools.Three measurements tools were used to assess adherence in children: two-day self-report,one month self-recall report (visual analogue scale) and unannounced pill count.

For the two-day self-report, patients were asked at follow up if they had missed any doses over the last two days.If they reported no missed doses, it was considered good adherence(>95%), while if they missed one dose it was considered poor adherence. For the one- month self-recall (visual analogue scale), the patient was asked to mark in a line to recall the way they took their medicines and thereafter the mark was measured using a 10-centimetre ruler and translated into percentages.If the mark measured below 9.5cm (equivalent to <95%) it was considered poor adherence, while if measured 9.5cms and above (equivalent to >95%) it was considered good adherence.

By pill count, patients were asked to bring their pill bottles and at random pills were counted. Pill count expectations were derived based on the equation: Number of pills actually taken divided by total number of pills which were supposed to be taken over that period. Anything between 95% and less was considered poor. For fixed-dose combination drugs (Duovir N, Triomune junior -2 pills per day), if more than 2 pills over a one-month period were counted, this was considered poor adherence and if 2 pills or less were counted, it was considered good adherence. For lopinavir based regimen (Didanosine, Abacavir and Alluvia -7 pills per day) which is Tanzanian second line therapy, if more than 8 pills were counted, this was considered poor adherence while if 8 pills or less were counted it was considered good adherence. For Efavirenz based regimen (Combivir and Efavirenz-3 pills per day), if more 4 pills were counted this was considered poor adherence while if ±4 pills were counted it was considered good adherence.

Data generated from the questionnaire was entered in the computer and was analysed using statistical package of social science (SPSS) version 16.0. Descriptive statistics were conducted first to summarize adherence rate measures and socio- demographic characteristics of the respondents. Multivariate analyses were run to find associations between the exposure variables and adherence. All values with a p value of < 0.05 were considered as statistically significant. To control for confounders, all variables with p value < 0.05 were subjected to stepwise logistic regressions.

Ethical clearance was obtained from Kilimanjaro Christian Medical University (KCMU) College Research and Ethics Review Committee and permission to carry out the study was obtained from the Executive Director of the hospital.

 

 

Demographic characteristics of respondents (Table 1) Of 183 patients, 92 (51%) were males and 91 (49%) were females. Majority (n=117; 61.7%) of respondents were adolescents aged 10-17 years and were attending school (n=160; 87.4%). Most (n=150; 82.0%) of caregivers were females. Majority (n=113; 61.7%) of the caregivers were biological parents, had completed primary school (n=113; 61.7%) and were employed (n=154; 84.2%).

Antiretroviral drug adherence levels

Adherence level was assessed by three methods. Good adherence was found by two- day self-report in 148 (80.9%), by visual analogue scalein 136 (73.4%), and by pill count in 64 (35%) patients. Only 45 (24.6%) patients had good adherence when subjected to all three measurements.

Medication and socio-economic factors that influence adherence to ART (Table 2)

Males were more adherent to ART as compared to females (OR=2.26, CI 1.05-4.87; p=0.04). Children who were prescribed fixed-dose combination of ARV drugs had better adherence as compared to those prescribed unfixed dose combination(OR=1.34, CI 0.62-3.08; p= 0.44), though this did not reach statistical significance. Those children who developed drug side-effects were significantly less likely to adhere to medication as compared to those who did not develop drug side effects(OR=0.19, CI 0.07- 0.56 p=0.01). Children who missed taking drug doses in six months period prior to interview were also less likely to adhere (OR= 0.40, CI 0.18-0.82; p=0.01).

Children whose caregivers had household monthly income was above 100,000TZS (OR= 0.44, CI 0.21-0.96;p=0.04) and afforded to transport their children to the clinic (OR= 3.4, CI 1.60-7.36; p=0.01) were more adherent to ART as compared to those with household monthly income below 100,000TZS and who could not afford to transport their children to clinic on regular basis. Children whose caregivers bought them additional nutritious food were more adherent than those who did not receive additional food (OR=2.93, CI 1.23-6.90; p=0.01).

Predictors of adherence

Multivariate logistic regression was undertaken to determine the predictors of adherence. There were six variables with p values < 0.05: sex, ARV side-effects, missed taking ARV in six months period, monthly household income, affording transportation to the clinic and providing additional food to children taking medication. Of these, only four remained significantly associated with more than 95% adherence to HAART: ARV side effects, missed doses in six months period, household monthly income and affording transportation to the clinic.

 

 

This study highlighted an adherence rate of only24.6% in this cohort.Though other studies have shown significantly better results with adherence ratesranging from 69% to 97.5% [6-10], among 159 HIV-positive adolescents of the REACH study, only 28.3% reported complete adherence the previous month by self report [11].There are several possible explanations for these differences. First, most respondents in this study were adolescents, who had been on ART between 1 year and 5 years as compared to other studies [6-9] in which the studied groups were on treatment for one year.In children on long-term treatment, compliance to medication tends to decrease with time [3]. Second, adolescents in this cohort provided their own account of their adherence as opposed to their caregivers, which was not the case in other studies where the caregivers were providing adherence reports. This only explains the difference when it is assumed that adolescents are less biased and more accurate than caregivers. Third, the adherence rate was obtained using three methods of assessment which was not the case in the other studies: Nabukeera et al used 3 and 7 days self- report and pill count methods [6]; Bhattacharya et al used 4 days recall [7]; Arrive et al used one month self-recall [8];Van Dyke 3 days self-report [9]; Bisimba et.al. 2 day self-report [10]; and Murphy et al. used one month self-recall [11]. To increase sensitivity and reliability of the assessment, more than one measure should be used because they complement each other.

Surprisingly, male children had better adherence than female (OR=2.26, CI 1.05-4.87; p=004). This is consistent with the findings reported by Bhattacharyaet al. [7], but inconsistent with that of Nabukeera et al. [6]. The explanation for this is not clear, but it could be explained, partly by cultural norms and taboos. In Tanzania, girls are more engaged in household activities than boys. In the course of accomplishing the given tasks, they might end up tired and hence forget to take their pills, resulting in poor adherence.

Children who were prescribed fixed dose combination ART had better adherence than those prescribed unfixed dose combination, though this did not reach statistical significance. This is in contrast to the findings reported by Nabukeera et al. in Uganda [6] and that of Martin et al. in USA [12] which showed that children who were taking complex regimens had better adherence than those on simple regimens. This was not the case in this study whereby those on unfixed combination were less likely to adhere to medication, possibly because of increased pill burden. Murphy et al. [11] found an inverse relationship between number of drugs and adherences noting more drugs were associated with poorer adherence and simplified regimens may improve adherence.

It was also found that; children who developed ARV drug side effects were less likely to adhere to medication than those who did not develop side effects. This finding is consistent with that reported by Paranthaman et al. in India [13] but inconsistent to the findings reported by Nabukeera et al. in Uganda [6] which showed that drug related factors did not affect adherence. In our study, respondents had been on treatment for more than one year and hence had an increased chance of developing side-effect; however, in the Nabukeera study respondents where only on ART for one year. To minimize the occurrence of drug side effects, more explanations of the drug side effects and how to manage them should be provided to both caregivers and children. Children who missed taking drug doses in the six months period prior to study were less likely to adhere to ART when evaluated by adherence measuring tools in this study, and this six months period history was not noted by other studies in the literature. The study results highlighted those children whose caregivers had good economic status, afforded to bring their children to clinic on regular basis and incurred extra cost for additional food for them; were moreadherent to medication as compared to their counterparts. These findings are similar to those reported by Bhattacharya et al. in New Delhi [7] which showed that children whose caregivers were of low socio-economic status had poor adherence. Empowering family members on income generating activities might raise household income and hence improve adherence.

 

 

In conclusion, only 24.6 %of patients had good adherence to ART when subjected to all three adherence measures which is lower than found in many other studies. Statistically significant predictors of poor adherence based on multivariate analysis includedexperiencing ARV drug side effects, having missed drugs doses in six months prior to study period, affording transportation to the clinic and level of household monthly income. To maximize adherence to ARV drugs: it is important to explain drug side-effects and how to manage these side-effects to both caregivers and children. This study also found empowering family members on income generating activities might raise household income and hence improve adherence.

Limitation

The main limitation of this study is recall bias as well as desirability bias which have been minimized by the-use of objective measures of adherence, pill count method in particular.

 

 

Authors declare no conflict of interest

 

 

Amos Haki Nsheha was involved in this study from the design, data collection, analysis and paper writing. Dorothy Elizabeth Dow participated in critical review of the research proposal, results and technical input. Gabriel Erick Kapanda contributed in data analysis and data interpretation. Bernadius Carmilus Hamel has participated in critical review, guidance and provided technical input throughout paper writing. Levina January Msuya provide expert supervision in all the steps of this study. All authors have read and approved the final version of the manuscript.

 

 

We thank Prof. Jules Tolboom for his critical review and expert advice in the development of research proposal as well as dissertation results. We also thank KCMC administration and management team for allowing us to conduct the research. Lastly special thanks to both caregivers and children who participated in the study.

 

 

Table 1: Patients socio-demographic characteristics

Table 2: Medication and socio-economic factors that influence adherence to ART

 

 

1. UNAIDS. UNAIDS Report on the Global AIDS Epidemic. 2010. www.unaids.org/documents/20101123_globalreport.em.pdf. Accessed on 23 November 2010.


2. Tanzania Commission for AIDS. Tanzania 2007-08 HIV and Malaria indicator Survey, Dar es Salaam. 2009. www.tacaids.go.tz/dmdocuments/THMIS%202007-08.pdf. Accessed on 25 November 2010.


3. Osterberg L and Blaschke T. Adherence to medication. New England Journal of Medicine.2005; 353 (5): 487-49. PubMed | Google Scholar


4. Shah CA. Adherence to Highly Active Antiretroviral Therapy (HAART) in pediatric patients infected with HIV: Issues and intervention. Indian Journal of Paediatrics. 2007;74 (1):55-60. PubMed | Google Scholar


5. Haberer J and Mellins C. Pediatric adherence to HIV Antiretroviral therapy. Curr HIV/AIDS Rep. 2009; 6 (4): 194-200. PubMed | Google Scholar


6. Nabukeera BN, Kalyesubula I, Kekitiinwa A, Byakika TJ and Musoke P. Adherence to antiretroviral therapy in children attending Mulago hospital, Kampala. Annals of Tropical Paediatrics. 2007; 27(2):123-131. PubMed | Google Scholar


7. Bhattacharya M and A.P Dubey. Adherence to antiretroviral therapy and its correlates among HIV- infected children at an HIV clinic in New Delhi. Annals of Tropical Paediatrics.2011; 31(4): 331-337. PubMed | Google Scholar


8. Arrive E, Anaky MF, Wemin ML, Diabate B, Rouet F, et al. Assessment of adherence to Highly Antiretroviral Therapy in a cohort of African HIV- Infected children in Abidjan, Cote d?lvoire. Journal of Acquired Immune Deficiency Syndrome. 2005; 40(4):498-500. PubMed | Google Scholar


9. Van Dyke RB, Lee S, Johnson GM, Andrew W, Kathleen M, Kenneth S et al. Reported adherence as a determinant of response to Highly Active Antiretroviral therapy in children who have Human Immunodeficiency Virus Infection. Paediatrics. 2002; 109(4); e61. PubMed | Google Scholar


10. Bisimba JE, Naubutu JP and Swai E.Adherence to antiretroviral therapy among children receiving therapy in a resource-poor setting. Journal of the International AIDS Society. 2008; 11(supp1): P115. PubMed | Google Scholar


11. Murphy DA,Sarr M,Durako SJ, Moscicki A, Wilson CM, Muenz LR. Barriers to HAART adherence among human immunodeficiency virus - infected adolescents. Arch Pediatric Adolescence Med. 2003; 157(3):249-255. PubMed | Google Scholar


12. Martin S, Elliot-DeSorbo DK, Wolters PL, Toledo-Tamula MA, Roby G, Zeichner S et al. Patient, caregiver and regimen characteristics associated with adherence to Highly Active Antiretroviral Therapy among HIV- infected children and adolescents. Pediatric Infectious Disease Journal. 2007; 26(1):61-67. PubMed | Google Scholar


13. Paranthaman K, Kumarasamy N, Bella D and Webster P. Factors influencing adherence to antiretroviral treatment in children with human immunodeficiency virus in South India- A qualitative study. AIDS Care. 2009; 21 (8): 1025-31. PubMed | Google Scholar